Clinical Trial Update: Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate [NA]

View source ↗

Summary

Clinical trial update of imatinib mesylate for various myeloproliferative and related neoplasms including CMML, CML, polycythemia vera, hypereosinophilic syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Hypereosinophilic Syndrome
• Mastocytosis
• Myelomonocytic Leukemia
• Polycythemia Vera

Drugs mentioned

• Imatinib mesylate (Imatinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia | NA | Status: COMPLETED | Results posted: 2022-01-04